| Name | 5-chloro-3-(2-trimethylsilylethynyl)pyridin-2-amine | 
|---|---|
| Synonyms | 
                                
                                5-chloro-3-(2-(trimethylsilyl)ethynyl)pyridin-2-amine
                                
                                
                                 5-chloro-3-trimethylsilanylethynylpyridin-2-ylamine 5-chloro-3-[2-(trimethylsilyl)ethynyl]-2-pyridinamine 2-amino-5-chloro-3-[(trimethylsilyl)ethynyl]pyridine 2-AMINO-5-CHLORO-3-(TRIMETHYLSILYL)ACETYLENYLPYRIDINE 5-Chloro-3-((trimethylsilyl)ethynyl)pyridin-2-amine  | 
                        
| Molecular Formula | C10H13ClN2Si | 
|---|---|
| Molecular Weight | 224.76200 | 
| Exact Mass | 224.05400 | 
| PSA | 38.91000 | 
| LogP | 3.12730 | 
| Symbol | 
                                
                                 
                                
                                 
                                
                                GHS05, GHS07  | 
                        
|---|---|
| Signal Word | Danger | 
| Hazard Statements | H302-H318 | 
| Precautionary Statements | P280-P305 + P351 + P338 | 
| RIDADR | NONH for all modes of transport | 
| HS Code | 2933399090 | 
| 
                                
                                
                                
                                
                                 ~99%  
                                    866318-90-3  | 
                        
| Literature: VERTEX PHARMACEUTICALS INCORPORATED? Patent: WO2005/95400 A1, 2005 ; Location in patent: Page/Page column 345; 346 ; WO 2005/095400 A1 | 
| 
                                
                                
                                
                                
                                
                                
                                 ~%  
                                    866318-90-3  | 
                        
| Literature: WO2011/137022 A1, ; | 
| Precursor 3 | |
|---|---|
| DownStream 5 | |
| HS Code | 2933399090 | 
|---|---|
| Summary | 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |